REVELATION BIOSCIENCES, INC. Common Unit, Outstanding
REVELATION BIOSCIENCES, INC. (REVB) had Common Unit, Outstanding of 21.14 thousand shares as of 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Balance Sheet › Equity › Limited Liability Company (LLC) Members' Equity
us-gaap:CommonUnitOutstanding · last filed 2023-03-30
- 2022-06-30: Common Unit, Outstanding 21.14K shares.
- 2022-03-31: Common Unit, Outstanding 21.14K shares.
- 2022-01-10: Common Unit, Outstanding 369.84K shares; Common Unit, Outstanding as first filed 1.29M shares.
- 2021-12-31: Common Unit, Outstanding 1.29M shares.
| Period end | Common Unit, Outstanding | Common Unit, Outstanding as first filed |
|---|---|---|
| 2022-06-30 | 21.14K shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 21.14K shares 10-Q · filed 2022-05-16 | |
| 2022-01-10 | 369.84K shares 10-K · filed 2023-03-30 | 1.29M shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 1.29M shares 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |